17.100
+2,40%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -31.5% | +36.5% | 2 / 3 | +11.5% | -4.92 pp | -3.68 pp | +26.3% | 0.19 | 4.25 | 1.784 | +11,5% | 105 | −31,5% | 4.25 | 6.87 | −38,1% |
| Pts | 0 | 8 | 8 | 4 | 0 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 17.100 (close price on 2026-10-19)EPS (TTM): 4.024
Financial charts
1.Revenue & growth
VND bn1.784Q2/26
1.Revenue & growth
VND bn1.784Q2/26
2.Profit & growth
VND bn122Q2/26
3.Profit mix (Penman)
VND bn758Q2/26
4.Margins & cost structure
%14.1%Q2/26
5.Returns & cash cycle
% · days69.2%Q2/26
6.Earnings quality & cash
VND bn11,2Q2/26
7.Asset structure
VND bn3.292Q2/26
8.Funding & debt health
VND bn · times3.292Q2/26
9.Revenue backlog
VND bn19,6Q2/26
10.Valuation
times · %4,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %834Q2/26
Adjusted EPS growth, latest quarter
-20.3%
Average adjusted EPS growth, 3 quarters
40.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26